EnligHTN German Observational Study of Renal Denervation for Uncontrolled Hypertension
This is a Post Market, Multi-center, Open Label, Observational Study. Approximately 500 Subjects With Uncontrolled Hypertension Will Undergo Renal Artery Ablation
Sponsor: Abbott Medical Devices
A observational or N/A phase clinical study on Uncontrolled Hypertension, this trial is completed. The trial is conducted by Abbott Medical Devices and has accumulated 11 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Mar 2019 — Jan 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Feb 2019 — Mar 2019 [monthly]
Completed
-
Oct 2018 — Feb 2019 [monthly]
Completed
-
Jun 2018 — Oct 2018 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Nov 2017 — Apr 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2017 — Nov 2017 [monthly]
Active Not Recruiting NA
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
For direct contact, visit the study record on ClinicalTrials.gov .